Radiation‑induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre Por Tainara Camelo Radiation‑induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre Read More »
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression Por Tainara Camelo Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression Read More »
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET Por Tainara Camelo Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET Read More »
Preoperative factors that predict pathologic nodal involvement in early‑stage HER2+ breast cancer: selecting cT1cN0 patientsfor treatment with neoadjuvant chemotherapy versus upfront surgery Por Tainara Camelo Preoperative factors that predict pathologic nodal involvement in early‑stage HER2+ breast cancer: selecting cT1cN0 patientsfor treatment with neoadjuvant chemotherapy versus upfront surgery Read More »
A Prospective Study of Sentinel Node Biopsy Omission in WomenAge ≥ 65 Years with ER+ Breast Cancer Por Adson Machado A Prospective Study of Sentinel Node Biopsy Omission in WomenAge ≥ 65 Years with ER+ Breast Cancer Read More »
Optimising first-line subtyping-based therapy in triple negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial Por Adson Machado Optimising first-line subtyping-based therapy in triple negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial Read More »
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 Por Adson Machado Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 Read More »
Gut microbiome in association with chemotherapy‐induced toxicities among patients with breast cancer Por Adson Machado Gut microbiome in association with chemotherapy‐induced toxicities among patients with breast cancer Read More »
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]) Por Adson Machado Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]) Read More »
Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study Por Adson Machado Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study Read More »
Refluxo Gastresofágico em Recém-Nascidos Por Ingrid Refluxo Gastresofágico em Recém-Nascidos Read More »
Resumo da Diretriz de Prática Clínica de Refluxo Gastroesofágico Pediátrico Naspghan-Espghan 2018 Por Ingrid Resumo da Diretriz de Prática Clínica de Refluxo Gastroesofágico Pediátrico Naspghan-Espghan 2018 Read More »
